These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Comparison of Theolair SR and Theo-Dur tablets. Domson JF, Hein EW, Sheen A, Sly RM. Ann Allergy; 1979 Oct; 43(4):220-2. PubMed ID: 555598 [Abstract] [Full Text] [Related]
23. Bioavailability of a slow-release theophylline capsule given twice daily to preschool children with chronic asthma: comparison with liquid theophylline. Sallent J, Hill M, Stecenko A, McKenzie M, Hendeles L. Pediatrics; 1988 Jan; 81(1):116-20. PubMed ID: 3336577 [Abstract] [Full Text] [Related]
24. [Serum concentrations of the pyridoxal and pyridoxal-5'-phosphate in children during sustained-release theophylline therapy]. Tanaka I, Ito Y, Hiraga Y, Fujino M, Kobayashi K. Arerugi; 1996 Oct; 45(10):1098-105. PubMed ID: 8958656 [Abstract] [Full Text] [Related]
28. Theophylline administration in children with asthma: optimal pulmonary function and possible tolerance to chronic administration. Katz RM, Rachelefsky GS, Siegel SC, Mickey R. Ann Allergy; 1983 Jan; 50(1):23-6. PubMed ID: 6849515 [Abstract] [Full Text] [Related]
31. Serum theophylline levels in adult asthmatics: comparison of oral sustained-release and microcrystalline preparations. Jones DT, Sears MR. N Z Med J; 1980 Sep 10; 92(667):196-8. PubMed ID: 6933358 [Abstract] [Full Text] [Related]
32. Theophylline serum levels unmodified by postprandial administration of a sustained-release preparation (Teonova). Cannizzaro GF, Pesce L, Zanoli P, Milani GF, Zannoni F, Pivirotto F. Int J Clin Pharmacol Res; 1988 Sep 10; 8(1):37-41. PubMed ID: 3366501 [Abstract] [Full Text] [Related]
33. [A comparative study of the pharmacokinetics and urinary metabolites of sustained-release theophylline syrup, granule and tablet preparations]. Horiuchi Y, Takemura T, Ueno K. Arerugi; 1991 Sep 10; 40(9):1186-93. PubMed ID: 1958133 [Abstract] [Full Text] [Related]
34. Rapid and sustained oral theophylline loading. An alternative to intravenous aminophylline therapy. Brown DL, Maddux MS, Organek HW, Bauman JL. Arch Intern Med; 1983 Apr 10; 143(4):794-6. PubMed ID: 6838301 [Abstract] [Full Text] [Related]
35. Intersubject variability of serum theophylline concentration after single dose of uncoated controlled release theophylline tablet administration in asthmatic patients. Raj NS, Guleria R, Misra A, Pande JN. Indian J Chest Dis Allied Sci; 1997 Apr 10; 39(3):143-7. PubMed ID: 9357147 [Abstract] [Full Text] [Related]
37. Reliability of salivary theophylline concentration monitoring in children with bronchial asthma following the administration of different drug formulations. Boner AL, Valletta EA, Plebani M, Biancotto R, Bellanti JA. Allergol Immunopathol (Madr); 1985 Apr 10; 13(5):393-8. PubMed ID: 4083233 [Abstract] [Full Text] [Related]
38. [Slow-release theophylline for the treatment of asthmatic children]. Iwasaki E, Baba M. Nihon Rinsho; 1996 Nov 10; 54(11):3102-7. PubMed ID: 8950962 [Abstract] [Full Text] [Related]
39. [Analysis of the theophylline pharmacokinetics of sustained-release theophylline (Theodur) dry syrup in children]. Okuma M, Iikura Y. Arerugi; 1999 Jun 10; 48(6):589-96. PubMed ID: 10423899 [Abstract] [Full Text] [Related]
40. [Anhydrous theophylline in micropellets with prolonged action in asthmatic children]. Massey LF, Escobedo V. Rev Alerg Mex (1987); 1989 Jun 10; 36(6):245-51. PubMed ID: 2699068 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]